PACK

STRUCTURAL ANALYST NOTE: PACK (Ranpak Holdings Corp.) Date: 2026-06-13 Current Price: $7.34

1. Structural Readiness

State: Context-Only Conservative Entry: — (Awaiting confirmed breakout) Aggressive/Pre-Breakout Entry: — (Not actionable on setup alone) Breakout Level: — (Not yet fired) Current Price: $7.34 Extension: — ATR Current: 5.0% (High)

Setup Analysis:

2. Thesis Layer

Thesis Classification: Tactical / Setup-Led Secular Exposure: None Named

At this date, there is no named secular thesis driving this specific trade. This is a tactical, setup-led name. The conviction must be derived entirely from the quality of the structural setup (which is currently forming) and the underlying business fundamentals. We do not invent a macro thesis to force a narrative; the trade is judged on the alignment of management expectations, operational momentum, and the technical structure.

3. Business Fundamentals

Company Overview: Ranpak Holdings Corp. is a leading provider of environmentally sustainable, systems-based product protection and end-of-line automation solutions for e-commerce and industrial supply chains. The company operates in the Materials sector, specializing in protective packaging systems (PPS) and automation.

Business Model & Revenue Streams:

• PPS Systems & Consumables: Ranpak sells systems (FillPak, PadPak, WrapPak, Geami, ReadyRoll) that convert paper into void-fill, cushioning, and wrapping materials. These are sold to distributors and select end-users.
• Automation: The company provides end-of-line automation to streamline void-filling and box closure.
• Channel Mix: Approximately 80% of total net revenue is derived from sales to distributors, while 40% of net revenue is derived from sales to e-commerce end-users.
• Installed Base: As of December 31, 2025, the company reported over 145,000 installed systems serving over 30,000 end-users.

Management Expectations (Source: 2026-03-05 Earnings Transcript):

• Automation Growth: Management anticipates automation revenue growth of 30%–50%, potentially exceeding $60 million and turning positive from an Adjusted EBITDA perspective.
• 2026 Guidance: On a constant currency basis, management expects net revenue growth of 5%–12.7% and Adjusted EBITDA growth of 5.4%–19.9% for 2026.
• Strategic Partnerships: The company has strengthened relationships with two of the world's largest e-commerce and retail leaders and elevated its position in automated box customization via a collaboration with Medline Industries. Management expects more than $1 billion in cumulative revenue from these relationships over the next 8–10 years.
• Labor Hedge: Management frames automation as a direct hedge against persistent labor shortages, wage inflation, and high turnover in warehouse environments.
• PPS Outlook: For PPS, management expects low- to high-single-digit volume growth in 2026, building on 2025 momentum despite a tough Q1 2025 comparison.

Recent Performance (Source: 2026-04-30 Filing):

• Automation Revenue: In Q1 2026, automation net revenue increased $7.1 million (112.7%) to $13.4 million, up from $6.3 million in Q1 2025.
• Revenue Mix: Automation products represented 10% of net revenue in 2025, up from 8% in 2024.
• 2025 Total Revenue: Generated $395.0 million in net revenue.

4. Archetype and Conviction

Archetype: Growth Leader Rationale: The name fits the Growth Leader archetype due to the rapid acceleration in its automation segment (112.7% growth in Q1 2026) and the strategic pivot toward high-margin, recurring-revenue automation solutions. The business is transitioning from a pure consumables play to a systems-and-automation provider, driven by structural labor pressures in the logistics sector.

Valuation & Financial Context:

• Financial Spine: Forward consensus EPS for FY1 is -0.21333 and FY2 is -0.073333. The company is currently in a pre-profitability phase for its automation segment, with management explicitly stating the segment is "turning positive from an Adjusted EBITDA perspective" in the near term.
• Conviction Stack:
• Thesis Strength: Moderate. The thesis is tactical, relying on the execution of the automation growth story rather than a broad macro tailwind.
• Evidence Quality: High. Multiple primary sources (earnings transcripts, SEC filings) confirm the 112.7% automation growth and the $1B+ long-term partnership pipeline.
• Structural Quality: Moderate. The setup is "Forming," meaning the technical structure is present but unconfirmed. The "High" ATR (5.0%) suggests the stock is volatile, which is typical for growth names in a breakout phase but increases risk.
• Rerating Potential: High, contingent on the automation segment achieving the projected $60M+ revenue and EBITDA positivity.

5. Invalidations, Strengths, and Gaps

What Would Strengthen the Case:

• Technical: A confirmed daily close above the established resistance level (breakout) with volume expansion, transitioning the coil to "Confirmed-Active."
• Fundamental: Q2 2026 earnings confirming the automation segment has turned positive on an Adjusted EBITDA basis as guided.
• Operational: Confirmation of the $1 billion cumulative revenue milestone from the Medline and e-commerce partnerships accelerating ahead of the 8–10 year timeline.

What Would Invalidate the Case:

• Fundamental: A significant miss on the 5%–12.7% net revenue growth guidance for 2026 or a failure of the automation segment to show continued double-digit growth.
• Macro: A sharp contraction in e-commerce volume that reduces demand for packaging systems.

Evidence Gaps:

• Specific Breakout Level: The exact price level for the breakout (resistance) is not defined in the current data, as the setup is still forming.
• Detailed Margin Data: While EBITDA positivity is expected, specific margin expansion figures for the automation segment are not provided in the current evidence block.
• Cash Flow: The financial spine indicates negative EPS, but specific free cash flow generation details for the current quarter are not explicitly detailed in the provided evidence.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: Automation revenue grew 112.7% to $13.4M in Q1 2026; Management expects automation to reach $60M+ revenue and turn EBITDA positive; Strong installed base of 145,000 systems driving recurring revenue. Key risks: Forward consensus EPS remains negative for FY1 and FY2; Setup is still forming with no confirmed breakout; High ATR (5.0%) indicates elevated volatility and risk of false breakouts. Sizing hint: Position size should be reduced relative to a confirmed breakout setup due to the "forming" status and negative earnings consensus. Expected path: Management expects automation to drive 30-50% revenue growth and EBITDA positivity; structural labor shortages should support long-term demand for automation solutions. Expected horizon: 6 to 12 months for the automation thesis to fully materialize and for the technical setup to resolve.